Anthony Nagle – Vice President and Managing Director, Fuld Europe
tnagle@fuld.com

Anthony Nagle joined Fuld in January 2005 as Vice President and Managing Director, Fuld Europe. Prior to Fuld Mr. Nagle’s career has included 17 years of international commercial & product development experience covering the pharmaceutical, consumer diagnostic and biopharmaceutical sectors.

Mr. Nagle has headed a newly established biopharmaceutical division for a top 20 multinational based in Denmark. Initial focus for revenue generation is the out licensing of early stage peptide based drugs. As a Senior Vice President of global marketing & product development he was responsible for a variety of marketing and licensing activities in the UK, Germany, China and New Zealand, including completing a number of in licensing and one out licensing deal to expand / enhance therapy area portfolio in the areas of gene therapy, drug delivery.

As a hands-on marketer for large multinationals, GlaxoSmithKline and Bayer, he brings practical knowledge and therapeutic area experience in diabetes, gastrointestinal & coagulation therapeutic areas which involved the development & execution of global product strategic plans as well as building probability based market models Mr. Nagle also brings with him general management experience as head of healthcare business in New Zealand as well as being a key team member that established a highly successful Joint Venture in the PR China.

Mr. Nagle is a Life science graduate, with a BSc with honours (cum laude) in Microbiology & Virology from Warwick University in the UK.